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Abstract
Problem: Sepsis is the leading cause of morbidity and mortality and antibiotic
administration within 60-minutes is a priority. The purpose of this quality improvement
project was to improve sepsis patient’s outcomes by administering parenteral antibiotics
within 60-minutes of a code sepsis (CS) activation.
Method: Observational descriptive design utilizing a retrospective medical record review
over a three-month period in 2020 and 2021. A purposive sampling of adult patients from
a Midwestern, metropolitan, Level II trauma and medical center emergency department
(ED) were selected.
Results: The administration of parental antibiotics once a sepsis bundle was activated was
essentially 28-minutes in 2020 and 2021 (t (416)=0.16, p=.874). This is well within the
recommended 60-minutes by Surviving Sepsis Campaign (SSC). In addition, there was a
weak relationship found between antibiotic administration time and LOS for 2020 (r=0.01; CI [-0.13, 0.11]; p=.910), and also for 2021 (r=0.02; CI [-0.11, 0.16]; p=.745).
Results of a Fisher exact test found home or self-care was significant (in 2020: 128
[100.81]; in 2021: 53 [80.19], p<.001). More patients were discharged to home in 2020
than in 2021.
Implications: Antibiotic administration times were less than 60-minutes in 2020 and 2021.
The LOS and final disposition were essentially unchanged. The Covid-19 pandemic may
influence these results. Regardless, sepsis remains a leading cause of death in adults and
continuous quality improvement may drive better outcomes.
Keywords: sepsis, sepsis bundle, and door-to-antibiotic time for sepsis
treatment
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Antibiotic Administration Time During a Code Sepsis
A leading cause of critical illness and hospital mortality is sepsis. Sepsis is a lifethreatening organ dysfunction condition caused by a dysregulated and inflammatory host
response to an infection (Coopersmith et al., 2018). Essentially one person dies every two
minutes from sepsis; hence, sepsis is a worldwide medical condition claiming the death of
258,000 people each year and is considered a medical emergency (Walters, 2018). In the
United States, there are more than 1.5 million cases of sepsis annually (Seymour, Gesten,
Prescott, & Friedrich, 2017). The Centers for Disease Control and Prevention (CDC)
reported the most common source (80%) for contracting illness originates within the
general community (CDC, 2016). A deceiving characteristic for early sepsis is a well- or
tired-appearing person who usually arrives in the emergency department (ED) or to a
primary care provider (PCP) for a general illness complaint. Early identification of sepsis
is critical, especially when there is a change in the patient’s condition. The restoration of
tissue perfusion and organ function becomes a primary goal in re-establishing and
maintaining hemodynamic stability from the inflammatory response (Makic & Bridges,
2018). Patient survival from sepsis and controlling the body’s response can be
challenging.
A “sepsis protocol” or “sepsis bundle” has evolved and is based on worldwide
evidence for the identification and management of sepsis. Kim and Sunghoon (2019)
reported the following symptoms as important identifiers for sepsis and are known as the
systemic inflammatory response syndrome (SIRS) criteria: abnormally high or low
temperature (T), elevated heart rate (HR), elevated respiratory rate (RR), low blood
pressure (BP) or mean arterial pressure (MAP) less than 65 mmHg, and unexplained
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altered mental status (AMS). Once identified, a sepsis bundle has been recommended to
be initiated to include a serum lactic acid, set of blood cultures, antibiotic administration,
crystalloids initiated parenterally at 30 mL/kg over one hour, and vasopressors if two or
more consecutive BP readings are low (Systolic BP <90 mmHg, or MAP <65 mmHg
(Kim and Sunghoon, 2019). While protocols and bundles may vary slightly, a Level II
Trauma and Medical Center in a large Midwestern, metropolitan area developed an
evidence-based protocol known as “code sepsis” (CS) to decrease mortality and improve
health outcomes for patients being treated for sepsis. The CS was developed to identify
and treat suspected sepsis and septic shock based on the Centers for Medicare and
Medicaid Services (CMS) sepsis core measures and guidelines from the Surviving Sepsis
Campaign (Coopersmith et al., 2018). The medical center has been utilizing CS to identify
and treat patients suspected of infection within the first six-hour period of suspicion. A CS
activation consists of a medical team at the organization responding to the early
recognition, early management and if needed, resuscitation of sepsis. The CS team
consists of a critical care registered nurse (CCRN), respiratory therapist (RT), pharmacist,
and an ED physician. When a patient is admitted with clinical symptoms of two or more
SIRS criteria, and suspected or documented infection, a CS is activated for prompt
intervention. Despite the CS team and CS bundle efforts, the administration time of the
initial dose of antibiotics has been identified as a consistent problem and as an opportunity
for improvement.
Timely antibiotic administration for patients suspected of infection is an essential
factor to reducing complications and mortality from sepsis; and, is recommended to occur
as soon as infection is identified or suspected (Kim and Sunghoon,2019). The purpose of
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this quality improvement project was to provide parenteral antibiotics within 60-minutes
of a CS activation. The aim of this project was to decrease antibiotic administration start
time by 10% over three-months. The outcome measures of interest were 1) Time of CS
activation, 2) Time antibiotic administration initiated, 3) Total length of hospital stay
(LOS), and 4) Final disposition upon discharge (e.g., home, rehabilitation facility, morgue,
etc). The question for study is: In hospitalized patients aged 18-years and older, what is
the effect on hospital LOS and final disposition when antibiotics were administered within
60-minutes of a CS activation compared to antibiotic administration occurring over 60minutes from CS activation?
Literature Review
The search engines used for this literature review were CINAHL, Cochrane
Library, and PUBMED. The key search terms were sepsis, sepsis bundle, and door-toantibiotic time for sepsis treatment using the Boolean operators AND and OR. Initially,
170 publications were retrieved; therefore, the search was further refined to include
greater than 18-years old, established or strong suspicion of infection, and two or more
SIRS criteria. Excluded were those less than 18-years old, no suspicion of infection, and
less than two SIRS criteria. This refined search yielded 70 publications. Finally, an
ancestry approach was used on select publications with a total of 13 publications
ultimately selected for this review.
The definition of sepsis is the dysregulated host response to an infection with
organ dysfunction resulting from an exaggerated inflammatory response (Kim &
Sunghoon, 2019). Sepsis is diagnosed when an infection is present and at least two SIRS
criteria are present: abnormal T, increased HR, low BP, and unexplained AMS (Kim &
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Sunghoon, 2019). Early identification and treatment for sepsis is critical to recovery and
survival; however, healthcare providers can be challenged when patients initially appear
well and seek medical attention for an otherwise routine illness (Makic & Bridges, 2018;
Coopersmith et al., 2018). Reduced mortality rates, hospital LOS, and hospital costs have
been associated with early identification and treatment for sepsis (Coopersmith et al.,
2018). An exaggerated inflammatory response to any type of infection can occur within
hours, days, or weeks from the invading organism (e.g., viral, bacterial, fungal, or
parasitic). The identification of infection may take hours to days, and serum, urine, or
other body fluid cultures may be negative. Because of these potential delays, the
identification of sepsis becomes challenging.
Sepsis is the body’s response to an infection when the immune system is
negatively affected when fighting against bacteria, viruses, fungi, and parasites. However,
the pathophysiology of sepsis is a far more complex interaction between the infectious
agent and host contributing to a sepsis condition. In the initial response to sepsis, the host
responds to the activation of pathogens (macrophages, monocytes, neutrophils, and natural
killer cells) through the binding of pathogen-associated molecular patterns (Gyawali,
Ramakrishna, & Dhamoon, 2019). As a result, proinflammatory cytokines are released
(TNF, IL-1, and IL-6) causing an activation and proliferation of leukocytes, upregulation
of endothelial adhesion molecules and chemokines expression, tissue factor production,
and the induction of hepatic acute phase reactants (Gyawali et al., 2019). The immune
response becomes overwhelmed resulting in damage and death of the host cells and
tissues.
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The unbalanced hemostasis in sepsis initiates both the inflammatory and
coagulation cascades suspected to be caused by the release of tissue factor from disrupted
endothelial cells. When the tissue factor is activated, the production of thrombin, platelets,
and the formation of platelet fibrin clots cause a decrease in local perfusion resulting in
tissue hypoxia and organ dysfunction (Gyawali et al., 2019). The immune system of sepsis
patients becomes powerless in fighting against secondary bacterial, viral, or fungal
infections due to the decrease in T-cells and decreased response to inflammatory
cytokines. Gyawali et al. (2019) reported a global depletion of CD4+ and CD8+ T-cells in
intensive care unit (ICU) patients who have died from sepsis. There is an alteration in the
body’s hemodynamics from a decreased delivery of oxygen to the cells resulting in
hypoperfusion (Gyawali et al., 2019). Hypoperfusion affects the body’s organs in several
ways. The inflammatory mediator prompts the dilations of the arterial and venous blood
flow and decreases the venous return causing hypotension and shock in sepsis patients
(Gyawali et al., 2019).
In the lungs, the alveolar-endothelial barrier is weakened and protein rich fluid
accumulates in the interstitial lung spaces decreasing lung compliance leading to an acute
respiratory distress syndrome (ARDS) (Gyawali et al., 2019). In the kidneys, an acute
kidney injury occurs due to the reduced renal perfusion, acute tubular necrosis, and the
deficiency in the microvasculature and tubules. For the gastrointestinal tract, the mucosal
lining is compromised leading to the leakage of bacteria in circulation making the host
susceptible to disease. In the liver, the bilirubin is decreased resulting in the production of
cholestatis (Gyawali et al., 2019). Due to endothelial changes in the blood-brain barrier,
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related to the entry of toxins, inflammatory cells, and cytokines, an altered mentation is
likely in sepsis patients. (Gyawali et al., 2019).
Because of the complex nature of sepsis, the estimated healthcare cost for sepsis
care is $27 billion per year with a one-year survival rate estimated to be less than 50%
(Afrefian et al., 2017). Hospital-related costs were based on the type of sepsis and the
population, but the treatment for any sepsis is consistently the most expensive syndrome in
US hospitals (Afrefian et al., 2017). The total hospital stay in terms of cost per patient
were between $13,292 and $75,015 (Paoli, 2017). The average length of stay for patients
admitted with sepsis without organ function is eight days, 16 days for sepsis cases do not
present on admission, and seven days for sepsis cases present on admission (Paoli, 2017).
The mortality rate for sepsis without organ dysfunction is 5.6%, 13.8% (sepsis does not
present on admission), and 4.5 % (sepsis cases present on admission) (Paoli, 2017).
A Surviving Sepsis Research Committee (the Committee), a consensus committee
of 16 international experts, convened to develop a Surviving Sepsis Campaign (SSC,
Coopersmith et al., 2018). The Committee addressed all aspects of sepsis (including
mortality rates, diagnostics, treatments, hospital LOS, and costs) by developing research
questions to determine the best evidence for reducing mortality from sepsis (Coopersmith
et al, 2018). Coopersmith et al. (2018) concluded the immediate administration of
parenteral antibiotics and in cases of an unknown pathogen, a combination of antibiotics,
may decrease mortality in septic patients. An antibiotic combination therapy is thought to
expedite the clearance of the offending pathogen and ensure at least one pathogen to be
sensitive to the treatment (Coopersmith et al, 2018). However, Coopersmith et al. (2018)
found no difference in the literature in administrating parenteral monotherapy vs
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combination therapy in mortality or outcomes in patients with sepsis. Of note, their
research on mono- or combination antibiotic therapy were of low quality and without
randomized controlled trials (Coopersmith et al., 2018). Hence, the coverage of broadspectrum antibiotic therapy was not included in the Committee practice guidelines on
sepsis (Coopersmith et al, 2018). Regardless, immediate antibiotic therapy is advocated to
assist the immune system and lessen the inflammatory response.
Early identification of sepsis can increase the initiation of treatment and
ultimately patient outcomes. Seymour et al. (2017) reviewed data from the New York
State Department of Health (NYSDOH) from April 1, 2014 to June 30, 2016. In this
retrospective study conducted from 185 hospitals within the NYSDOH jurisdiction
requiring all hospitals to report patients with sepsis and septic shock, an electronic case
report form consisting of data on demographic characteristics, coexisting conditions,
characteristics of sepsis and septic shock, illness severity, and outcomes were evaluated
(Seymour et al., 2017). The time and date of the sepsis protocol initiation of a three-hour
bundle and six-hour bundle for patients were compared. They found the delay in
completing a three-or the six-hour bundle and the administration of a broad-spectrum
antibiotics was associated with higher risk adjustment in hospital mortality (Seymour et
al., 2017). The authors offered three explanations to support early diagnosis and treatment.
First, rapid administration of antibiotics decreased the burden of the pathogen on the body,
reduced the host inflammatory response, and resulted in a reduction in organ dysfunction
(Seymour et al., 2017). Second, the serum lactate level provided a quick measurement for
clinicians in identifying otherwise unrecognized shock and prepared for an improved
delivery of sepsis treatment (Seymour et al., 2017). Finally, providers who could swiftly
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suspect infection and worsening organ dysfunction reflected an enhanced delivery of
sepsis treatment and outcomes (Seymour et al, 2017). The limitations of this study
included non-randomization, broad-spectrum antibiotics being limited with the antibiotics
only being measurable with positive cultures, and hospitals may have differed in common
pathogens and antimicrobial resistance (Seymour et al., 2017). Improved outcomes were
consistently reported when certain serum diagnostics, such as lactic acid and antibiotic
therapy was evaluated and initiated sooner than later.
In a study conducted within the United Kingdom (UK), McGregor (2014)
evaluated completion of a “sepsis six” bundle of six essential items identified to be of
benefit if completed within an hour: 1) Blood cultures, 2) Full blood count and lactic acid,
3) Parenteral fluid administration, 4) Parenteral antibiotic administration, 5)
Monitoring urine output, and 6) Application of oxygen. After several Plan Do-Study-Act
(PDSA) cycles including education, implementation, and public display of results
regarding the sepsis care pathway, they found a decrease from six-hours to 1.4 hours for
antibiotic administration. Reportedly, there is an 8% increased mortality for every hour of
antibiotic administration delay (Kumar et al. [2006], cited in McGregor, 2014). Thus,
reducing the door-to-drug time for antibiotic administration in septic patients may be
significantly reduced with a concentrated effort to enhance the timely completion of a
sepsis bundle.
Donabedian’s model of structure, process, and outcomes were used in this project
to bring awareness of early recognition in patterns and nature of sepsis patients quickly
and improve efficiency in treating sepsis (Yankovsky, Gajewski, & Dunton 2016). The
compliance of utilizing the CS bundle (structure) will guide healthcare providers or staff
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to improve the practice of administering antibiotics within the first hour of suspicion of
infection to sepsis patients. The model will guide the advancement of knowledge and
developing skills to engage and build confidence in healthcare providers or staff in
promptly completing all the components in the CS bundle (process). The goal is to
decrease patient morality and organ dysfunction (outcomes) caused by sepsis (Yankovsky
et al., 2016).

Method
Design
An observational, descriptive design utilizing a retrospective medical record
review from February 1, 2020 through April 30, 2020 was conducted for baseline
information regarding CS antibiotic administration time. A PDSA cycle included CS
education and data reporting on the CS bundle was completed for the staff in February
2021. From February 1, 2021 through April 30, 2021, the same data was collected and
compared to the 2020 data.
Setting
A Midwestern, metropolitan, Level II trauma and medical center emergency
department (ED). The medical center serves a population of over three million residents;
however, the area has over a dozen hospitals serving the same population. There are
approximately 460 inpatient beds, consisting of 36 intensive care unit (ICU) beds, 26
transitional care unit (TCU) and 398 general medicine or surgery beds for adult patients.
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Sample
A purposive sampling of adult patients with an admitting or final diagnosis of
sepsis. Inclusion criteria were those 18-years and older who were hospitalized and had a
CS activation. Exclusion criteria were participants younger than 18-years of age, not
hospitalized, or without a CS activation.
Approval Processes
Approval for the quality improvement PDSA cycle to improve timely antibiotic
administration times was obtained from the medical center administration. Additional
approvals were obtained from the Doctor of Nursing practice (DNP) clinical scholarship
committee and graduate school from the university. Finally, approvals were obtained by
the organization’s institutional review board (IRB) and the university IRB.
There were no anticipated risks to patients as this was a retrospective medical
record review. A benefit to this study included observed patient outcomes related to
antibiotic administration times.
Data Collection/Analysis
Data was collected from a medical record review in the electronic medical record
(EMR). The baseline data was from those patients with a CS activation between February
1, 2020 through April 30, 2020. The second data set included those patients with a CS
activation between February 1, 2021 through April 30, 2021. The data collected included
the number of CS activations; demographic information (i.e., age, gender, race/ethnicity);
time of parenteral antibiotic administration (time initiated); hospital LOS; and final
disposition (i.e., home, rehabilitation facility, morgue, or other). All data will be deidentified as 20-1, 20-2, 20-3 and so on for the 2020 cohort, and 21-1, 21-2, 21-3, and so
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on for the 2021 cohort. Data analysis included descriptive statistics, Fisher’s Exact test,
Pearson’s Correlation and Two-Tailed Independent Sample t -Test.
Procedures
A team of key stakeholders was already in progress when the primary investigator
(PI) for this quality improvement effort joined the team. A pharmacy representative was
also a member of the quality improvement team. The team identified timely antibiotic
administration as an opportunity for improvement. Based on the antibiotic administration
data, the plan was to provide additional education on CS team activation and the CS
bundle, past and current data reflected on posters posted in staff areas, and a reevaluation
of antibiotic administration times. A Sepsis Implementation and Compliance Campaign
(SICC) was developed to include relevant data on posters and other educational
opportunities for staff to bring awareness of the importance of antibiotic administration
times in patients with sepsis. The process began when a CS was activated and its order set
was selected. The order set had a sepsis identifier to generate a message in the EMR which
then sent a page to the pharmacist alerting the pharmacist about the CS. The orders were
to be reviewed expeditiously by the pharmacist to ensure appropriate dosing, antibiotic
coverage, and prompt delivery of an intravenous broad-spectrum antibiotic to the nurse
caring for the patient.
Results
The total number medical records reviewed for the year 2020 and 2021 was 474
(N=474). In 2020 there were 264 (n=264) and 2021 there were 210 (n=210). Ages ranged
from 18-99 years, and in 2020, the mean age was 63.25 years (SD=17.82); in 2021, the
mean age was 65.07 years (SD=17.49). For gender, in 2020, there were 146 females
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(n=146, 55%) and 118 males (n=118, 45%). In 2021, there were 105 females (n=105,
50%) and 105 males (n=105, 50%). For Race/Ethnicity in 2020, there were 129
Caucasians (n=129, 49%); 126 African Americans (n=126, 48%); six Asians (n=6, 2%);
two Multiracial (n=2, 1%) and one Russian (n=1, 0%). In 2021, Race/Ethnicity revealed
111 African Americans (n=111, 53%), 99 Caucasian (n=99, 47%), zero Multiracial (n=0,
0%), zero Asian (n=0, 0%), and zero Russian (n=0, 0%).
The mean antibiotic administration time once a sepsis bundle was activated was
28.20 minutes (SD=14.19) for 2020, and the mean for 2021 was 27.98 minutes
(SD=13.91). A two-tailed independent samples t-test was conducted between the two
means. The difference was not significant based on an alpha value of 0.05
(t (416)=0.16, p=.874). Essentially antibiotic administration times were the same
for both years.
Next, the mean hospital length of stay for the year 2020 was 7.55 days (SD=6.78)
and for 2021 it was 7.42 days (SD=6.77). A Pearson correlation between the time of
antibiotic administration and LOS revealed a weak relationship for 2020 (r=-0.01; CI [0.13, 0.11]; p=.910), and also for 2021 (r=0.02; CI [-0.11, 0.16]; p=.745). The hospital
LOS was essential not dependent on antibiotic administration times.
For the final disposition of the year 2020/2021, there were 128/53 discharged to
home or self-care; 36/39 expired; 34/35 discharged to a Skilled Nursing Facility; 11/10
discharged to Custodial or Supportive Care; 4/3 discharged to Long-term Acute Care; 6/6
discharged to a Rehabilitation facility; 13/7 discharged to Nursing Facility: Medicaid; 5/5
discharged to Hospice: Medical Facility, 20/30 discharged to Home Health care Service,
2/8 discharged to Hospice: Home, 3/9 Left Against Medical Advice/ Discontinued care,
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and 2/5other (psych unit, currently hospitalized, inpatient hospital [transfer to another
hospital], LTAC, and other facility not defined elsewhere). Results of a Fisher exact test
were significant based on an alpha value of 0.05, where only home or self-care was
significant (in 2020: 128 [100.81]; in 2021: 53 [80.19], p<.001). More patients were
discharged to home in 2020 than in 2021.
Discussion
The administration of parental antibiotics once a sepsis bundle was activated was
essentially 28-minutes in 2020 and 2021.This is well within the recommended 60-minutes
by SSC. In addition, there was no relationship found between antibiotic administration
time and LOS or antibiotic administration time and final disposition. The SICC poster and
badge buddies were introduced to ED staff to bring awareness in the gaps of knowledge
on signs and symptoms of sepsis, however, this does appear to have resulted in improved
times or disposition. Interestingly, more patients were discharged to home in 2020 than
2021. The cause for this was beyond the scope of this project.
A strength of this project was an adequate sample size evaluated during similar
times for both years. A limitation was the Covid-19 pandemic was officially declared in
March 2020. This may have influenced hospital LOS or final disposition as the cause for
sepsis was evaluated. A recommendation for future study might be to assess the criteria
for home discharge, or the study should be repeated after the pandemic.
Conclusion
The introduction of a SICC campaign did not influence antibiotic administration
times, however, antibiotic administration times were less than 60-minutes before and after
the SICC campaign was implemented. The LOS and final disposition were essentially
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unchanged. Regardless, sepsis remains a leading cause of death in adults and continuous
quality improvement may drive better outcomes.

CODE SESPSIS DRUG ADMINISTRATION

17

References
Arefian, H., Heublein, S., Scherag, A., Brunkhorst, F.M., Younis, M.Z., Moerer, O., &
Hartmann, M. (2017). Hospital-related cost of sepsis: A systematic review.
Journal of

Infection, 74, 107-117. https://doi.org/10.1016/j.jinf.2016.11.006

Bloos et al. (2017). Effect of a multifaceted educational intervention for anti-infectious
measures on sepsis mortality: A cluster randomized trial. Springer. 1602-1612.
doi: 10.1007/s00134-017-4782-4
Bosmann, M., & Ward, P. A. (2013). The Inflammatory response to sepsis. PubMedNIH, 34 (3), 129-136. doi:10.1016/j.it2012.09.004
Butcher. L (2016). Stepping up against Sepsis. Hospital & Health Networks. 38-42.
Retrieved from www.hhnmag.com
Conover, W. J., & Iman, R. L. (1981). Rank transformations as a bridge between
parametric and nonparametric statistics. The American Statistician, 35(3), 124129. https://doi.org/10.1080/00031305.1981.10479327
Coopersmith, C.M., DeBacker, D., Deutschman, C.S., Ferrer, R., Lat, I., Machado,F.R. &
Rhodes, A. (2018). Surviving sepsis campaign: Research priorities for sepsis and
septic shock. Intensive Care Medicine, 44, 1400-1425.
https://doi.org/10.1007/s00134-018-5175-z
Gyawali, B., Ramakrishna,K., & Dhamoon, A. (2019). Sepsis: The evolution in
definition, pathophysiology, and management. SAGE Open Medicine, 7, 1-12.
Doi:10.117/2050312119835043
Intellectus Statistics [Online computer software]. (2021). Intellectus Statistics.
https://analyze.intellectusstatistics.com/

CODE SESPSIS DRUG ADMINISTRATION

18

Kim, H., & Sunghoon, P. (2019). Sepsis: Early recognition and optimized treatment.
Tuberculosis and Respiratory Diseases, 82, 6-14. doi: 10.4046/trd.2018.0041
Makic, M.B., & Bridges, E. (2018). CE: Managing sepsis and septic shock: Current
guidelines and definitions. American Journal of Nursing, 118, 34-39. doi:
10.1097/01.NAJ.0000530223
McGregor C. (2014). Improving time to antibiotics and implementing the "Sepsis 6".
BMJ Quality Improvement Reports,1443, 13. Doi:10.1136/bmjquality.u202548
Razali, N. M., & Wah, Y. B. (2011). Power comparisons of Shapiro-Wilk, KolmogorovSmirnov, Lilliefors and Anderson-Darling tests. Journal of Statistical Modeling
and Analytics, 2(1), 21-33.
Seymour, C.W., Gesten, F., Prescott, H.C., & Friedrich, M.E. (2017). Time to treatment
and mortality during mandated emergency care for sepsis. The New England
Journal of Medicine, 376, 2235-2244. doi: 10.1056/NEJMoa1703058
Walters, E. (2018). Raising awareness for sepsis, sepsis screening, early recognition, and
treatment in the emergency department. Journal of Emergency Nursing, 44, 224227. https://doi.org/10.1016/j.jen.2017.10.008
Yankovsky, A., Gajewski, B. J., & Dunton, N. (2016). Trends in Nursing Care Efficiency
From 2007 to 2011 on Acute Nursing Units. Nursing Economic$, 34(6), 266–2.

CODE SESPSIS DRUG ADMINISTRATION

19

Appendix A
Figure 1. Antibiotic Administration Time after CS activation

Year

Note. The mean antibiotic administration time once a sepsis bundle was activated
was 28.20 minutes (SD=14.19) for 2020, and the mean for 2021 was 27.98 minutes
(SD=13.91). A two-tailed independent samples t-test was conducted between the two
means. The difference was not significant based on an alpha value of 0.05 (t
(416)=0.16, p=.874). Essentially antibiotic administration times were the same for both
years.
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Appendix B
Figure 2. The Mean Hospital LOS

Year

Note. The mean hospital length of stay for the year 2020 was 7.55 days (SD=6.78)
and for 2021 it was 7.42 days (SD=6.77). A Pearson correlation between the time of
antibiotic administration and LOS revealed a weak relationship for 2020 (r=-0.01; CI [0.13, 0.11]; p=.910), and also for 2021 (r=0.02; CI [-0.11, 0.16]; p=.745). The hospital
LOS was essential not dependent on antibiotic administration times.
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Appendix C
Table 1. Final Disposition for patients with the diagnosis of sepsis
Month
2020
Year

2021
Year

χ2

128[10
0.81]

53[80
.19]

3
7.42

Expired

36[41.
77]

39[33
.23]

Skilled Nursing Facility

34[38.
43]

35[30
.57]

11[11.
70]

10[9.
30]

Long Term Acute Care

4[3.90]

3[3.1
0]

Rehab: Inpatient

6[6.68]

6[5.3
2]

Nursing Facility: Medicaid

13[11.
14]

7[8.8
6]

Hospice: Medical Facility

5[5.57]

5[4.4
3]

other

2[3.90]

5[3.1
0]

20[27.
85]

30[22
.15]

2[5.57]

8[4.4
3]

3[6.68]

9[5.3
2]

Final Disposition Nominal
Home or Self Care

Custodial or Supportive Care

Home Health Care Svc
Hospice: Home
Left Against Medical
Advice/Discontinued Care

d
f
1
1

Note. Results of a Fisher exact test were significant based on an alpha value of
0.05, where only home or self-care was significant (in 2020: 128 [100.81]; in 2021: 53
[80.19], p<.001). More patients were discharged to home in 2020 than in 2021.

p
<
.001

